![Unparalleled Access to Clinical Data: One Year On - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety Unparalleled Access to Clinical Data: One Year On - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety](https://www.pharsafer.com/wp-content/uploads/2017/11/EMA-Logo-large.jpg)
Unparalleled Access to Clinical Data: One Year On - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety
![Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency](https://www.ema.europa.eu/sites/default/files/chmp_statement_clinical_trials.jpg)
Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency
![EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN](https://metab.ern-net.eu/wp-content/uploads/2018/06/33841578_464265530653872_8714539216823910400_o-1024x576.png)
EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN
![Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/19af1aea-f1c6-4663-8f82-bc7fdeb5f789/gr1_lrg.jpg)
Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer
EU Medicines Agency on Twitter: "‼️ Joint @EU_Health, #HMA, @EMA_News press briefing on new Clinical Trials Regulation will be broadcast live 🔴 today, 25 January, from 11:00 CET. #EMAPresser #ClinicalTrials 👉 https://t.co/yTddHobOXb
![The European Medicines Agency still has a way to go towards clinical trial transparency - The Pharmaceutical Journal The European Medicines Agency still has a way to go towards clinical trial transparency - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/02/clinical-transparency-lack-of-european-medicines-agency-14-927x617.jpg)